Modulating neurotoxicity through CX3CL1/CX3CR1 signaling

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Limatola, Cristina ^a,b   Ransohoff, Richard M ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

CX3CL1; CX3CR1; Microglia; Neurotoxicity; Signaling

Indexed keywords

EID: 84905685785     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00229     Document Type: Review

References (80)

1. Allan, S. M., Tyrrell, P. J., and Rothwell, N. J. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640. doi: 10.1038/nri1664
2. Arnoux, I., Hoshiko, M., Mandavy, L., Avignone, E., Yamamoto, N., and Audinat, E., (2013). Adaptive phenotype of microglial cells during the normal postnatal development of the somatosensory "Barrel" cortex. Glia 61, 1582-1594. doi: 10.1002/glia.22503
3. Bachstetter, A. D., Morganti, J. M., Jernberg, J., Schlunk, A., Mitchell, S. H., Brewster, K. W., et al. (2011). Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 32, 2030-2044. doi: 10.1016/j.neurobiolaging.2009.11.022
4. Bertollini, C., Ragozzino, D., Gross, C., Limatola, C., and Eusebi F (2006). Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacol. 51, 816-821. doi: 10.1016/j.neuropharm.2006.05.027
5. Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., and Lamb, B. T. (2010). Regulation of tau pathologybythe microglial fractalkine receptor. Neuron 68, 19-31. doi: 10.1016/j.neuron.2010.08.023
6. Bialas, A. R., and Stevens, B. (2013). TGF-β signaling regulates neuronalC1qexpres-sion and developmental synaptic refinement. Nat. Neurosci. 16, 1773-1782. doi: 10.1038/nn.3560
7. Biber, K., Neumann, H., Inoue, K., and Boddeke, H. W. (2007). Neuronal "On" and "Off" signals control microglia. Trends Neurosci. 30, 596-602. doi: 10.1016/j.tins.2007.08.007
8. Biber, K., Owens, T., and Boddeke, E. (2014).Whatismicroglianeurotoxicity(Not)? Glia 62, 841-854. doi: 10.1002/glia.22654
9. Blomster, L. V., Vukovic, J., Hendrickx, D. A., Jung, S., Harvey, A. R., Filgueira, L., et al. (2011). CX3CR1 deficiency exacerbates neuronal loss and impairs early regenerative responses in the target-ablated olfactory epithelium. Mol. Cell. Neurosci. 48, 236-245. doi: 10.1016/j.mcn.2011. 08.004
10. Boison, D., Chen, J. F., and Fredholm, B. B. (2010). Adenosine signaling and function in glial cells. Cell Death Differ. 17,1071-1082. doi: 10.1038/cdd.2009.131
11. Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., et al. (2006). Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924. doi: 10.1038/nn1715
12. Catalano, M., Lauro, C., Cipriani, R., Chece, G., Ponzetta, A., Di Ange-lantonio, S., et al. (2013). CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes. J. Neuroimmunol. 263, 75-82. doi: 10.1016/j.jneuroim.2013.07.020
13. Cho, S. H., Sun, B., Zhou, Y., Kauppinen, T. M., Halabisky, B., Wes, P., et al. (2011). CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J. Biol. Chem. 286, 32713-32722. doi: 10.1074/jbc.M111. 254268
14. Chora, A. A., Fontoura, P., Cunha, A., Pais, T. F., Cardoso, S., Ho, P. P., et al. (2007). Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 117, 438-447. doi: 10.1172/ JCI28844
15. Cipriani, R., Villa, P., Chece, G., Lauro, C., Paladini, A., Micotti, E., et al. (2011). CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J. Neurosci. 31, 16327-16335. doi: 10.1523/JNEUROSCI.3611-11. 2011
16. Crain, J. M., Nikodemova, M., and Watters, J. J. (2013). Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J. Neurosci. Res. 91, 1143-1151. doi: 10.1002/jnr. 23242
17. Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., et al. (2005). ATP mediates rapid microglial response to local brain injuryin vivo. Nat. Neurosci. 8, 752-758. doi: 10.1038/nn1472
18. De Simone, R., Ajmone-Cat, M. A., and Minghetti, L. (2004). Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine receptor interaction. Mol. Neurobiol. 29, 197-212. doi: 10.1385/MN:29:2:197
19. Denes, A., Ferenczi, S., Halâsz, J., Környei, Z., and Kovâcs, K. J. (2008). Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focalcerebral ischemiain mouse. J. Cereb. BloodFlowMetab. 28,1707-1721. doi: 10.1038/jcbfm.2008.64
20. Donohue, M. M., Cain, K., Zierath, D., Shibata, D., Tanzi, P. M., and Becker, K. J. (2012). Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke. Stroke 43, 2300-2306. doi: 10.1161/STROKEAHA.112.657411
21. Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., et al. (2009). Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461, 282-286. doi: 10.1038/ nature08296
22. Fredholm, B. B., Jonzon, B., and Lindgren, E. (1983). Inhibition of noradrenaline release from hippocampal slices by a stable adenosine analogue. Acta Physiol. Scand Suppl. 515, 7-10.
23. Fuhrmann, M., Bittner, T., Jung, C. K., Burgold, S., Page, R. M., Mitteregger, G., et al. (2010). Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat. Neurosci. 13, 411-413. doi: 10.1038/nn. 2511
24. Fuller, A. D., and Van Eldik, L. J. (2008). MFG-E8 regulates microglial phagocytosis of apoptotic neurons. J. Neuroimmune Pharmacol. 3, 246-256. doi: 10.1007/s11481-008-9118-2
25. Garcia, J. A., Pino, P. A., Mizutani, M., Cardona, S. M., Charo, I. F., Ransohoff, R. M., et al. (2013). Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation. J. Immunol. 191, 1063-1072. doi: 10.4049/jimmunol.1300040
26. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., et al. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330,841-845. doi: 10.1126/science.1194637
27. Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., et al. (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressingmicroglia. Proc. Natl. Acad. Sci. U.S.A. 95, 10896-10901. doi: 10.1073/pnas.95.18.10896
28. Hoshiko, M., Arnoux, I., Avignone, E., Yamamoto, N., and Audinat, E. (2012). Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex. J. Neurosci. 32, 15106-15111. doi: 10.1523/JNEUROSCI.1167-12.2012
29. Huang, D., Shi, F. D., Jung, S., Pien, G. C., Wang, J., Salazar-Mather, T. P., et al. (2006). The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20, 896-905. doi:10.1096/fj.05-5465com
30. Kim, K. W., Vallon-Eberhard, A., Zigmond, E., Farache, J., Shezen, E., Shakhar, G., et al. (2011). In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 118:e156-e167. doi: 10.1182/blood-201104-34894619
31. Krathwohl, M. D., and Kaiser, J. L. (2004). Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22, 109-118. doi: 10.1634/stemcells.22-1-109
32. Kuhn, H. G., Dickinson-Anson, H., and Gage, F. H. (1996). Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16, 2027-2033.
33. Lastres-Becker, I., Innamorato, N. G., Jaworski, T., Râbano, A., Kügler, S., Van Leuven, F., et al. (2014). Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain 137, 78-91. doi: 10.1093/brain/awt323
34. Lauro, C., Cipriani, R., Catalano, M., Trettel, F., Chece, G., Brusadin, V., et al. (2010). AdenosineA1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacol. 35, 1550-1559. doi: 10.1038/npp.2010.26
35. Lauro, C., Di Angelantonio, S., Cipriani, R., Sobrero, F., Antonilli, L., Bru-sadin, V., et al. (2008). Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 180, 7590-7596. doi: 10.4049/jimmunol.180.11. 7590
36. Lee, S., Varvel, N. H., Konerth, M. E., Xu, G., Cardona, A. E., Ran-sohoff, R. M., et al. (2010). CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 177, 2549-2562. doi: 10.2353/ajpath.2010. 100265
37. Leonardi-Essmann, F., Emig, M., Kitamura, Y., Spanagel, R., and Gebicke-Haerter, P. J. (2005). Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia. J. Neuroimmunol. 160, 92-101. doi: 10.1016/j.jneuroim.2004.11.012
38. Limatola, C., Lauro, C., Catalano, M., Ciotti, M. T., Bertollini, C., Di Angelan-tonio, S., et al. (2005). Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 166, 19-28. doi: 10.1016/j.jneuroim.2005.03.023
39. Liu, Z., Condello, C., Schain, A., Harb, R., and Grutzendler, J. (2010). CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis. J. Neurosci. 30, 17091-17101. doi: 10.1523/JNEUR0SCI.4403-10.2010
40. Lyons, A., Lynch, A. M., Downer, E. J., Hanley, R., O'Sullivan, J. B., Smith, A., et al. (2009). Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J. Neurochem. 110, 1547-5156. doi: 10.1111/j.1471-4159.2009.06253.x
41. Maggi, L., Scianni, M., Branchi, I., D'Andrea, I., Lauro, C., and Limatola, C. CX(3)CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front Cell Neurosci. 5:22. doi: 10.3389/fncel.2011.00022
42. Maggi, L., Trettel, F., Scianni, M., Bertollini, C., Eusebi, F., Fredholm, B. B., et al. LTP impairment byfractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). J. Neuroimmunol. 215, 36-42. doi: 10.1016/j.jneuroim.2009.07.016
43. Mantovani, A., Sica, A., and Locati, M. (2005). Macrophage polarization comes of age. Immunity 23, 344-346. doi: 10.1016/j.immuni.2005.10.001
44. Meucci, O., Fatatis, A., Simen, A.A., and Miller, R. J. (2000). Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 97, 8075-8080. doi: 10.1073/pnas.090017497
45. Mills, J. H., Alabanza, L. M., Mahamed, D. A., and Bynoe, M. S. (2012). Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis. J. Neuroinflammation 9:193. doi: 10.1186/1742-2094-9-193
46. Mills, J. H., Thompson, L. F., Mueller, C., Waickman, A. T., Jalkanen, S., Niemela, J., et al. (2008). CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 105, 9325-9330. doi: 10.1073/pnas. 0711175105
47. Mizuno, T., Kawanokuchi, J., Numata, K., and Suzumura, A. (2003). Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 979, 65-70. doi: 10.1016/S0006-8993(03)02867-1
48. Mizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., and Cardona, A. E. (2012). The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188, 29-36. doi: 10.4049/jimmunol.1100421
49. Morganti, J. M., Nash, K. R., Grimmig, B. A., Ranjit, S., Small, B., Bickford, P. C., et al. (2012). The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J. Neurosci. 32, 14592-14601. doi: 10.1523/JNEUROSCI.0539-12.2012
50. Nash, K. R., Lee, D. C., Hunt, J. B. Jr., Morganti, J. M., Selenica, M. L., Moran, P., et al. (2013). Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy. Neurobiol. Aging 34, 1540-1548. doi: 10.1016/j.neurobiolaging.2012.12.011
51. Neher, J. J., Emmrich, J. V., Fricker, M., Mander, P. K., Thery, C., and Brown, C. (2013). Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc. Natl. Acad. Sci. U.S.A. 110, E4098-E4107. doi: 10.1073/pnas. 1308679110
52. Neher, J. J., Neniskyte, U., Zhao, J. W., Bal-Price, A., Tolkovsky, A. M., and Brown, G. (2011). Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J. Immunol. 186, 4973-4983. doi: 10.4049/jimmunol. 1003600
53. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells are highlydynamic surveillants ofbrainparenchymainvivo. Science 308,1314-1318. doi: 10.1126/science.1110647
54. Noda, M., Doi, Y., Liang, J., Kawanokuchi, J., Sonobe, Y., Takeuchi, H., et al. (2011). Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J. Biol. Chem. 286, 2308-2319. doi: 10.1074/jbc.M110.169839
55. Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., et al. (2012). Identification of a microglia phenotype supportive of remyelination. Glia 60, 306-321. doi: 10.1002/glia.21266
56. Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., and Bickford, P. C. (2011). CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflammation 8:9. doi: 10.1186/1742-2094-8-9
57. Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., et al. (2011).Synaptic pruning by microglia is necessary for normal brain development. Science 333,1456-1458. doi: 10.1126/science.1202529
58. Pimentel-Coelho, P. M., Michaud, J. P., and Rivest, S. (2013). Evidence for agender-specific protective role of innate immune receptors in a model of perinatal brain injury. J. Neurosci. 33, 11556-11572. doi: 10.1523/JNEUROSCI.0535-13.2013
59. Ponomarev, E. D., Maresz, K., Tan, Y., and Dittel, B. N. (2007). CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J. Neurosci. 27, 10714-10721. doi: 10.1523/JNEUROSCI.1922-07.2007
60. Ponomarev, E. D., Veremeyko, T., and Weiner, H. L. (2013). MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61, 91-103. doi: 10.1002/glia.22363
61. Ragozzino, D., Di Angelantonio, S., Trettel, F., Bertollini, C., Maggi, L., Gross, C., et al. (2006). Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci. 26,10488-10498. doi: 10.1523/JNEUROSCI.3192-06.2006
62. Ransohoff, R. M., and Brown, M. A. (2012). Innate immunity in the central nervous system. J. Clin.Invest. 122, 1164-1171. doi: 10.1172/JCI58644
63. Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B.A., et al. (2011). CX3CR1 deficiencyleads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci. 31, 16241-16250. doi: 10.1523/JNEUROSCI.3667-11.2011
64. Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., et al. (2012). Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691-705. doi: 10.1016/j.neuron.2012.03.026
65. Schulz, C., Gomez Perdiguero, E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., et al. (2012). A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86-90. doi: 10.1126/science.1219179
66. Scianni, M., Antonilli, L., Chece, G., Cristalli, G., Di Castro, M. A., Limatola, C,et al. (2013). Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. J. Neuroinflammation 10:108. doi: 10.1186/1742-209410-108
67. Sierra, A., Abiega, O., Shahraz, A., and Neumann, H. (2013). Janus-faced microglia: beneficial and detrimental consequences of microglia phagocytosis. Front. Cell. Neurosci. 7:1-22. doi: 10.3389/fncel.2013.00006
68. Sierra, A., Encinas, J. M., Deudero, J. J., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., et al. (2010). Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7, 483-495. doi: 10.1016/j.stem.2010.08.014
69. Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., et al. (2002). Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125, 59-65. doi: 10.1016/S0165-5728(02)00033-4
70. Sun, H., Benardais, K., Stanslowsky, N., Thau-Habermann, N., Hensel, N., Huang, D,et al. (2013). Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)-in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. PLoS ONE 8:e72926. doi: 10.1371/journal.pone.0072926
71. Tremblay, M. E., Lowery, R. L., and Majewska, A. K. (2010). Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 8:e1000527. doi: 10.1371/journal.pbio.1000527
72. Ueno, M., Fujita, Y., Tanaka, T., Nakamura, Y., Kikuta, J., Ishii, M., et al. (2013). Layer V cortical neurons require microglial support for survival during postnatal development. Nat. Neurosci. 16, 543-551. doi: 10.1038/nn.3358
73. Vukovic, J., Colditz, M. J., Blackmore, D. G., Ruitenberg, M. J., and Bartlett, P. F.Microglia modulate hippocampal neuralprecursor activityinresponse to exercise and aging. J. Neurosci. 32, 6435-6443. doi: 10.1523/JNEUROSCI.5925-11.2012
74. Wang, D. D., Tian, T., Dong, Q., Xu, X. F., Yu, H., Wang, Y., et al. (2014). Tran-scriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphisminduceddysfunctions ofthe centralnervous system. Hippocampus 24, 65-78. doi: 10.1002/hipo.22204
75. Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., and Naguib, M. (2013). Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol. Aging 34, 2843-2852. doi: 10.1016/j.neurobiolaging.2013.06.003
76. Wynne, A. M., Henry, C. J., Huang, Y., Cleland, A., and Godbout, J. P. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 24, 1190-1201. doi: 10.1016/j.bbi.2010.05.011
77. Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., et al. (2014). Trancriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274-288. doi: 10.1016/j.immuni.2014.01.006
78. Zhan, Y., Paolicelli, R. C., Sforazzini, F., Weinhard, L., Bolasco, G., Pagani, F., et al. (2014). Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 17, 400-406. doi: 10.1038/nn.3641
79. Zujovic, V., Benavides, J., Vige, X., Carter, C., and Taupin, V. (2000). Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29,305-315. doi: 10.1002/(SICI)1098-1136(20000215)29:4<305:: AID-GLIA2>3.0.CO;2-V
80. Zujovic, V., Schussler, N., Jourdain, D., Duverger, D., and Taupin, V. (2001). In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS. J. Neuroimmunol. 115, 135-143. doi: 10.1016/S0165-5728(01)00259-4